Opportunity: Transforming waste eggshells into high-purity Calcium Carbonate (CaCO3) through a patented process, offering sustainable solutions for high-value sectors like pharmaceuticals, cosmetics, and food.

Market: A £16bn global Calcium Carbonate market, with significant demand for sustainable, high-purity alternatives in industries such as cosmetics, pharma, and food production.

Competitive Advantage: A patented, low-carbon process that extracts CaCO3 from waste eggshells, offering eco-friendly, cost-efficient alternatives to traditional mining methods and reducing landfill waste and CO2 emissions.

Strategic Focus: Scaling production to 5,000 tonnes annually in the UK, with plans to expand into Europe and North America. Targeting sustainability-focused industries and licensing the technology for broader market reach.

Investment Required: Funding production scale-up, operational expansion, and market entry.

Location: UK (Initial focus)
Sector: Sustainability / Manufacturing
Investment Sought: £600,000
Equity Offered: 20%

The Business:
This innovative company addresses the significant issue of waste eggshells, which contribute to CO2 emissions and landfill overfill. By utilising a patented process, they produce high-purity Calcium Carbonate (CaCO3) for industries such as pharmaceuticals, cosmetics, and paints. The approach is sustainable, offering a cost-efficient, low-carbon alternative to traditional CaCO3 mining methods, and aligns with the increasing global demand for environmentally conscious solutions.

The Market:
The global Calcium Carbonate market is valued at £16bn, with precipitated CaCO3 (PCC) accounting for one-third of this figure. The company initially targets the UK market with plans to sell 5,000 tonnes annually, generating projected revenues exceeding £8m and an EBITDA of £6.2m by year five. International demand extends across Europe, the US, and China, supported by a growing egg processing industry expanding by over 10% annually.

Traction and Achievements:

• Secured £400k in grants and £390k in equity investment.

• Developed an operational pilot plant to validate the process.

• Signed a Letter of Intent (LOI) for a 75-tonne supply, with two additional draft LOIs totalling over 500 tonnes in demand.

• Engaged in advanced discussions with multinational companies in pharmaceuticals and dietary supplements.

The Competition:
The main competitors are traditional suppliers of mined or ground Calcium Carbonate, such as Omya and Imerys, and producers of Precipitated Calcium Carbonate (PCC). This company’s sustainable process stands out due to its lower carbon footprint, cost efficiency, and alignment with environmental regulations. Titanium Dioxide, often used as an alternative, is being phased out in the EU, further increasing the demand for sustainable solutions.

Growth & Future Prospects:

Key growth opportunities include:

• Scaling up to a 5,000-tonne production plant in the UK, serving as a model for international licensing.

• Expanding into high-value sectors such as pharmaceuticals, cosmetics, and food industries.

• Developing partnerships with global industry leaders for licensing and production expansion.

Exit strategies include licensing the technology to industry leaders and forming strategic partnerships with global players focused on sustainability and innovative materials.

Risk Warning:
Investing in early-stage businesses involves significant risks, including illiquidity, loss of investment, and dilution. Investments of this nature should be part of a diversified portfolio. These opportunities are not covered by the Financial Services Compensation Scheme (FSCS). Seek independent financial advice before proceeding.